BIIB vs MRK
Biogen Inc · Merck & Company Inc
Relative return (rebased to 100)
Key stats
| Metric | BIIB | MRK |
|---|---|---|
| Price | $253.25 | $148.05 |
| Market Cap | $37.44B | $364.98B |
| P/E | 28.95 | 19.99 |
| P/B | 1.98 | 8.13 |
| P/S | 3.78 | 5.61 |
| ROE | 6.8% | 40.7% |
| Net Margin | 13.1% | 28.1% |
| Gross Margin | 117.7% | — |
| Revenue Growth | 2.2% | 1.3% |
| Dividend Yield | — | 2.22% |
| EPS | $8.75 | $7.40 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.